This patent teaches the use of the CD34+, lineage negative hematopoietic stem cell as a target for the in vitro screening and identification of drugs. For example, libraries may be screened for ability to inhibit or stimulate proliferation, or alternatively to induce differentiation into various lineages.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.